About Tomorrow’s Health

After more than a decade in the making, Tomorrow’s Health is finally here! Located in Kennewick, WA, our laboratory will be providing cutting edge testing capabilities for the local Tri-Cities community and beyond.

In response to the current COVID-19 pandemic that is gripping the entire world in its deadly embrace, we are responding to the call for increased lab capacity by providing COVID-19, Influenza A/B and comprehensive respiratory pathogen testing using state-of-the-art technology.

In company with COVID-19 testing, we offer a wide menu of laboratory tests, including thyroid function, reproductive health, comprehensive metabolic panel, complete blood count, lipid panel, hormone panel, various cancer screenings, and much more!

Leveraging the latest in next generation sequencing (NGS) technology, we will begin with respiratory pathogen testing, and will quickly move to the diagnosis of other infectious diseases, such as those of the urinary tract, bloodstream and gastrointestinal tract. This type of testing is quickly proving its worth, particularly in the areas of severe disease.

We then plan on moving into the human genomics arena where we wish to help catalyze a healthcare revolution. A revolution where healthcare becomes personalized and preventative, a revolution where we unlock the exponentially growing potential of understanding the human genome, a revolution where knowing the entire genome sequence of each individual will significantly improve his or her health and well-being.

The revolution is upon us – let’s carry it out together!

Tomorrow's Health Location
Tomorrow’s Health will provide each of our patients with next generation preventive health care that is personalized using his/her unique DNA sequence. After each patient’s entire genome has been sequenced, we will utilize comprehensive interpretations from ongoing human genetics and clinical research to help counsel our patients on how to prevent or mitigate the onset of disease and other conditions they have a genetic predisposition to experience in the future.
We strongly believe in our philosophy of taking care of tomorrow’s health…today. Like it says in the proverb “An ounce of prevention is worth a pound of cure.” A lifestyle that promotes wellness and health living and is empowered with the knowledge of genomic medicine can steer a person to a longer healthier life. We hope to change the healthcare focus to prevention rather than the current curative approach.

We are committed to running one of if not the first healthcare clinic that implements the knowledge of the entire genome sequence into our patients daily healthcare. We will partner with the best companies and leaders in genomic medicine to bring preventive and personalized healthcare to everyone.

Tomorrow’s Health is an authorized Medical Test Site in the State of Washington. Our CLIA can be found here.

Our History

Brent HouseBrent House is the Founder of Tomorrow’s Health.  He was a Lieutenant Commander in the U.S. Navy early in 2008, and worked development of a malaria vaccine and drug development at the Naval Medical Research Center (NMRC) and the Walter Reed Army Institute of Research (WRAIR) in Bethesda, Maryland. Tomorrow’s Health was born out of a conference he attended on the use of human genetic information to help medical professionals make drug treatment information.   One of the speakers predicted that within 5 years, the cost to sequence an entire human genome would dip below $1,000.

It was at this point that the vision came to his mind. He imagined a patient going into their clinic, where the clinic not only possessed the patient’s medical history, but also his/her entire genome sequence. The patient’s medical providers would then use the genome sequence to “personalize” the patient’s medical care. As new research became available, it could immediately be applied to each patient’s known genome sequence. This would allow continuous real-time updates of each patient’s “personalized” medical record.

He added to his vision over time the importance of the “personalized” practice of medicine and that it should be focused on preventive (vice reactive) measures. Though the information within the genome certainly can be used in typical reactive medicine, the benefits will more completely be realized in preventive practices.

He knew at the time that it was too early to begin this type of business, but determined that he would start it up when the time was right. That time is now!